Levant B - Search Results

1

Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.

Levant B, Grigoriadis DE, DeSouza EB. Levant B, et al. J Pharmacol Exp Ther. 1992 Sep;262(3):929-35. J Pharmacol Exp Ther. 1992. PMID: 1356154

2

Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.

Levant B, Nemeroff CB. Levant B, et al. J Pharmacol Exp Ther. 1990 Jul;254(1):330-5. J Pharmacol Exp Ther. 1990. PMID: 1973198

3

Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907].

Witkin JM, Dijkstra D, Levant B, Akunne HC, Zapata A, Peters S, Shannon HE, Gasior M. Witkin JM, et al. Among authors: levant b. J Pharmacol Exp Ther. 2004 Mar;308(3):957-64. doi: 10.1124/jpet.103.059980. Epub 2004 Jan 7. J Pharmacol Exp Ther. 2004. PMID: 14711932

4

The dopamine D3/D2 agonist (+)-PD-128,907 [(R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)] protects against acute and cocaine-kindled seizures in mice: further evidence for the involvement of D3 receptors.

Witkin JM, Levant B, Zapata A, Kaminski R, Gasior M. Witkin JM, et al. Among authors: levant b. J Pharmacol Exp Ther. 2008 Sep;326(3):930-8. doi: 10.1124/jpet.108.139212. Epub 2008 Jun 19. J Pharmacol Exp Ther. 2008. PMID: 18566292

5

D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function.

Levant B, McCarson KE. Levant B, et al. Neurosci Lett. 2001 Apr 27;303(1):9-12. doi: 10.1016/s0304-3940(01)01692-5. Neurosci Lett. 2001. PMID: 11297811

6

Inhibition of [3H]quinpirole binding by a monoamine oxidase inhibitor in subcellular fractions of rat striatum.

Levant B, Bancroft GN. Levant B, et al. Life Sci. 1998;63(18):1643-51. doi: 10.1016/s0024-3205(98)00433-0. Life Sci. 1998. PMID: 9806217

7

Differential distribution of D3 dopamine receptors in the brains of several mammalian species.

Levant B. Levant B. Brain Res. 1998 Aug 3;800(2):269-74. doi: 10.1016/s0006-8993(98)00529-0. Brain Res. 1998. PMID: 9685676

8

Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.

Levant B. Levant B. Brain Res. 1995 Nov 6;698(1-2):146-54. doi: 10.1016/0006-8993(95)00879-u. Brain Res. 1995. PMID: 8581473

9

Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.

Levant B, Nemeroff CB. Levant B, et al. J Pharmacol Exp Ther. 1992 Jul;262(1):348-55. J Pharmacol Exp Ther. 1992. PMID: 1625208

10

In vivo occupancy of D2 dopamine receptors by 7-OH-DPAT.

Levant B, Bancroft GN, Selkirk CM. Levant B, et al. Synapse. 1996 Sep;24(1):60-4. doi: 10.1002/(SICI)1098-2396(199609)24:1<60::AID-SYN7>3.0.CO;2-E. Synapse. 1996. PMID: 9046077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results